Travis C Mickle - President & CEO, Kempharm, Inc
As of August 30, 2021
Travis C Mickle Net Worth
- Net worth is estimated to be at least $15.83M
- Owns at least 130,424 units of Kempharm, Inc stock
Travis C Mickle Compensation at Kempharm, Inc in 2020
- Earned a $530,450 salary
- Received a total compensation of $967,979
Travis C Mickle Trading
- Largest purchase of shares was 5,000 units , worth over $44.61K on August 30, 2021
- In total has made about 19 transactions over 6 years
- Usually trades in February, June, August and March, with the busiest year in 2021, 2017, 2020, 2019 and 2016
Travis C Mickle
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
Travis C Mickle Mailing Address
- Mailing address is 2656 Crosspark Road Suite 100 Coralville IA 52241 IA
Kempharm, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Option Awards
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|
| Travis C. Mickle, Ph.D. | 2020 | $530,450 | - | $291,748 | $134,381 | $11,400 | $967,979 |
| Travis C. Mickle, Ph.D. | 2019 | $527,875 | - | - | $825,807 | $6,492 | $1,360,174 |
| Sven Guenther, Ph.D. | 2020 | $374,792 | $10,000 | $124,285 | $51,193 | $13,061 | $563,331 |
| Sven Guenther, Ph.D. | 2019 | $363,875 | - | - | $311,906 | $11,950 | $687,731 |
| R. LaDuane Clifton, CPA | 2020 | $350,200 | - | $134,827 | $51,193 | $4,894 | $541,114 |
| R. LaDuane Clifton, CPA | 2019 | $348,500 | - | - | $311,906 | $4,081 | $664,487 |
| No matching records found | |||||||
Source: https://www.sec.gov/Archives/edgar/data/1434647/000143774921010498/kmph20210429_def14a.htm
Kempharm, Inc Insider Trading
- The most recent transaction was 935 units bought on September 20, 2021 by R. Laduane Clifton worth over $8.03K
- In the last 6 years, insiders at Kempharm, Inc sold an estimated value of $15.5K and bought an estimated value of $9.19M
- The most active traders are R. Laduane Clifton, CFO, Travis C Mickle, President & CEO, and Gordon K Johnson, Chief Business Officer
- Insider trading is most common in May, with the busiest year in 2019
KEMPHARM, INC Insider Trades
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||